Absence of degeneration of adrenergic neurones after prolonged treatment of newborn rats with debrisoquin.
D000818:Animals; D000831:Animals, Newborn; D001369:Axons / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D003647:Debrisoquin / Q000008:administration & dosage / Q000494:pharmacology*; D003864:Depression, Chemical; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D005260:Female; D006651:Histocytochemistry; D007274:Injections, Intraperitoneal; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D008856:Microscopy, Fluorescence; D009410:Nerve Degeneration / Q000187:drug effects*; D009474:Neurons / Q000201:enzymology; D051381:Rats; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D014649:Vas Deferens / Q000294:innervation
D002395:Catecholamines; D007546:Isoquinolines; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D003647:Debrisoquin